| 11001 | DTI TBSS L2 Uncinate fasciculus R | GCST90384520 | 3.91e-03 |
| 11002 | Pain type(s) experienced in last month - None of the above | Pain | UKBB00000631 | 3.91e-03 |
| 11003 | BA-exvivo rh area V2 | GCST90003231 | 3.91e-03 |
| 11004 | ICD10 N81: Female genital prolapse | GCST90454214 | 3.91e-03 |
| 11005 | Migraine without aura | FING00000821 | 3.90e-03 |
| 11006 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T235 | ECGA000235 | 3.89e-03 |
| 11007 | HippSubfield lh volume CA4-head | GCST90002682 | 3.87e-03 |
| 11008 | DTI autoptx MD atr l tract | GCST90385222 | 3.87e-03 |
| 11009 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485 | ECGA000485 | 3.86e-03 |
| 11010 | aparc-pial rh area lingual | GCST90003186 | 3.82e-03 |
| 11011 | Other anxiety disorders | FING00000960 | 3.81e-03 |
| 11012 | Main speciality of consultant (recoded) - Anaesthetics | Summary Administration | UKBB00000413 | 3.81e-03 |
| 11013 | T1 CAT volume R CrusI | GCST90384120 | 3.80e-03 |
| 11014 | IMPA1 levels | GCST90469610 | 3.80e-03 |
| 11015 | CELA3A levels | GCST90468702 | 3.77e-03 |
| 11016 | DTI autoptx L2 ptr r tract | GCST90385186 | 3.75e-03 |
| 11017 | Tiglylcarnitine (C5:1-DC) levels | GCST90199800 | 3.75e-03 |
| 11018 | Estimated glomerular filtration rate (creatinine) | GCST90428447 | 3.75e-03 |
| 11019 | NOS1 levels | GCST90470062 | 3.73e-03 |
| 11020 | IDP dMRI ProbtrackX ISOVF slf r | GCST90004547 | 3.72e-03 |
| 11021 | CDK8_CCNC levels | GCST90240825 | 3.72e-03 |
| 11022 | Prostate cancer | GCST90011808 | 3.71e-03 |
| 11023 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T11 | ECGU000011 | 3.70e-03 |
| 11024 | Overall health rating | General health | UKBB00000621 | 3.69e-03 |
| 11025 | Eye problems/disorders - Cataract | Eyesight | UKBB00000230 | 3.68e-03 |
| 11026 | Types of transport used (excluding work) - Cycle | Physical activity | UKBB00000877 | 3.66e-03 |
| 11027 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000718 | 3.65e-03 |
| 11028 | IDP dMRI TBSS OD Anterior limb of internal capsule L | GCST90004419 | 3.65e-03 |
| 11029 | MNDA levels | GCST90469927 | 3.65e-03 |
| 11030 | Arm predicted mass (left) | Impedance measures | UKBB00000049 | 3.64e-03 |
| 11031 | Ischemic stroke | GCST90018644 | 3.64e-03 |
| 11032 | Sphingomyelin_33:1_[M+H]1+ levels | GCST90060229 | 3.63e-03 |
| 11033 | DTI TBSS MO Medial lemniscus L | GCST90384629 | 3.63e-03 |
| 11034 | Mean corpuscular volume (UKB data field 30040) | GCST90468086 | 3.62e-03 |
| 11035 | DLL1 levels | GCST90469004 | 3.62e-03 |
| 11036 | Congenital malformations of heart and great arteries | FING00000336 | 3.62e-03 |
| 11037 | Red blood cell erythrocyte count (UKB data field 30010) | GCST90468098 | 3.60e-03 |
| 11038 | Impedance of whole body | Impedance measures | UKBB00000360 | 3.59e-03 |
| 11039 | Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary Administration | UKBB00000466 | 3.58e-03 |
| 11040 | HSIL lesion of the cervix uteri | FING00000624 | 3.57e-03 |
| 11041 | LTBR/SIRPB1 ratio | GCST90315339 | 3.57e-03 |
| 11042 | Main speciality of consultant (recoded) - General medicine | Summary Administration | UKBB00000416 | 3.56e-03 |
| 11043 | SLC4A1 levels | GCST90470663 | 3.55e-03 |
| 11044 | HippSubfield lh volume subiculum-body | GCST90002669 | 3.55e-03 |
| 11045 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488 | ECGA000488 | 3.53e-03 |
| 11046 | Temporomandibular joint disorders, including avohilmo | FING00001355 | 3.52e-03 |
| 11047 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128) | GCST90320947 | 3.51e-03 |
| 11048 | BA-exvivo rh area entorhinal | GCST90003234 | 3.50e-03 |
| 11049 | DTI TBSS FA Corticospinal tract R | GCST90384386 | 3.47e-03 |
| 11050 | Osteochondrodysplasia with defects of growth of tubular bones and spine | FING00000910 | 3.46e-03 |
| 11051 | Viral hepatitis (PheCode 70) | GCST90475552 | 3.45e-03 |
| 11052 | IGFBP4 levels | GCST90469530 | 3.45e-03 |
| 11053 | Other alveolar and parietoalveolar pneumonopathy (PheCode 504) | GCST90476033 | 3.44e-03 |
| 11054 | X-24328 levels | GCST90200624 | 3.39e-03 |
| 11055 | Neurofibromatosis, type 2 | FING00000867 | 3.39e-03 |
| 11056 | Colorectal cancer, excluding all cancers (controls excluding all cancers) | FING00000317 | 3.38e-03 |
| 11057 | T1 FreeSurfer DKT lh precentral thickness | GCST90384246 | 3.38e-03 |
| 11058 | KIF22 levels | GCST90469682 | 3.37e-03 |
| 11059 | RSPO1/RSPO3 ratio | GCST90315790 | 3.36e-03 |
| 11060 | IDP dMRI ProbtrackX FA atr l | GCST90003927 | 3.35e-03 |
| 11061 | ESAM/PDGFB ratio | GCST90314714 | 3.35e-03 |
| 11062 | Impedance of arm right (UKB data field 23109) | GCST90468172 | 3.31e-03 |
| 11063 | Myocardial infarction | circulatory system | UKBB00000491 | 3.29e-03 |
| 11064 | SPINT1/SUSD2 ratio | GCST90315878 | 3.27e-03 |
| 11065 | PACS2 levels | GCST90470141 | 3.27e-03 |
| 11066 | Dupuytren's disease | GCST90301252 | 3.24e-03 |
| 11067 | Vascular/heart problems diagnosed by doctor - Angina | Medical conditions | UKBB00000896 | 3.24e-03 |
| 11068 | ENPP7 levels | GCST90469118 | 3.24e-03 |
| 11069 | aparc-DKTatlas rh area lingual | GCST90003276 | 3.23e-03 |
| 11070 | IDP dMRI TBSS OD Posterior limb of internal capsule R | GCST90004420 | 3.22e-03 |
| 11071 | Volume of left anterior amygdaloid area | GCST90474934 | 3.21e-03 |
| 11072 | Obesity related asthma | FING00000897 | 3.20e-03 |
| 11073 | Number of non-cancer illnesses (weighted GWA) | GCST90267291 | 3.20e-03 |
| 11074 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000719 | 3.19e-03 |
| 11075 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T499 | ECGU000499 | 3.19e-03 |
| 11076 | Congenital lactase deficiency | FING00000329 | 3.19e-03 |
| 11077 | CDH5/LGALS4 ratio | GCST90313956 | 3.19e-03 |
| 11078 | Age when finished full-time education (weighted GWA) | GCST90267281 | 3.18e-03 |
| 11079 | Morning/evening person (chronotype) | Sleep | UKBB00000483 | 3.17e-03 |
| 11080 | Paroxysmal tachycardia | FING00001151 | 3.17e-03 |
| 11081 | TPPP3 levels | GCST90470948 | 3.17e-03 |
| 11082 | Retinal thickness (functional principal component 2) | GCST90455722 | 3.16e-03 |
| 11083 | CXCL5/SERPINE1 ratio | GCST90314354 | 3.14e-03 |
| 11084 | Polycystic ovarian syndrome | FING00001182 | 3.13e-03 |
| 11085 | aparc-DKTatlas rh volume lateraloccipital | GCST90002902 | 3.12e-03 |
| 11086 | TNFRSF11B levels | GCST90243158 | 3.11e-03 |
| 11087 | Foveal thickness | GCST90624113 | 3.08e-03 |
| 11088 | Lysophosphatidylcholine (26:0) [sn1] levels | GCST90024188 | 3.07e-03 |
| 11089 | GABBR2 levels | GCST90241230 | 3.07e-03 |
| 11090 | aparc-pial rh area caudalmiddlefrontal | GCST90003177 | 3.07e-03 |
| 11091 | Radial peak diastolic strain rate | GCST90019014 | 3.05e-03 |
| 11092 | 4-acetamidobutanoate levels | GCST90243440 | 3.04e-03 |
| 11093 | Total lipids in very small VLDL | GCST90500810 | 3.01e-03 |
| 11094 | IDP dMRI ProbtrackX ISOVF fma | GCST90004535 | 3.01e-03 |
| 11095 | Time spent outdoors in winter | Sun exposure | UKBB00000819 | 3.01e-03 |
| 11096 | Diastolic blood pressure | GCST90472778 | 3.00e-03 |
| 11097 | CLK2 levels | GCST90240975 | 2.99e-03 |
| 11098 | Volume of left paralaminar nucleus | GCST90474895 | 2.95e-03 |
| 11099 | Current Smoker | FING00000371 | 2.94e-03 |
| 11100 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T192 | ECGA000192 | 2.93e-03 |
| 11101 | IDP dMRI TBSS L1 Cerebral peduncle L | GCST90004090 | 2.93e-03 |
| 11102 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T449 | ECGU000449 | 2.89e-03 |
| 11103 | Urate levels (UKB data field 30880) | GCST90468107 | 2.88e-03 |
| 11104 | Diverticular disease of intestine | FING00000471 | 2.88e-03 |
| 11105 | Chromatiales abundance in stool | GCST90032318 | 2.87e-03 |
| 11106 | RUVBL1 levels | GCST90470509 | 2.87e-03 |
| 11107 | Fruit intake (standard GWA) | GCST90267282 | 2.86e-03 |
| 11108 | EPHB4/ESAM ratio | GCST90314679 | 2.86e-03 |
| 11109 | ICD10 O14: Pre-eclampsia | GCST90454233 | 2.85e-03 |
| 11110 | Nonalcoholic steatohepatitis | FING00000879 | 2.83e-03 |
| 11111 | DTI TBSS L3 Retrolenticular part of internal capsule R | GCST90384544 | 2.82e-03 |
| 11112 | ICD10 C53: Malignant neoplasm of cervix uteri | GCST90454202 | 2.82e-03 |
| 11113 | CAG-269 sp001915995 abundance in stool | GCST90032266 | 2.81e-03 |
| 11114 | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | GCST90004166 | 2.81e-03 |
| 11115 | BAIAP2/MME ratio | GCST90313453 | 2.81e-03 |
| 11116 | aparc-a2009s lh volume G-precentral | GCST90002953 | 2.79e-03 |
| 11117 | Volume of right basal nucleus | GCST90475015 | 2.79e-03 |
| 11118 | CCS levels | GCST90468594 | 2.79e-03 |
| 11119 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T500 | ECGU000500 | 2.79e-03 |
| 11120 | Diverticulosis (PheCode 562.1) | GCST90476076 | 2.78e-03 |
| 11121 | wg rh intensity-contrast pericalcarine | GCST90003847 | 2.78e-03 |
| 11122 | aparc-Desikan rh area lingual | GCST90003119 | 2.78e-03 |
| 11123 | GIPC2 levels | GCST90469347 | 2.77e-03 |
| 11124 | Coxarthrosis | FING00000362 | 2.76e-03 |
| 11125 | aparc-a2009s rh area Pole-occipital | GCST90003412 | 2.76e-03 |
| 11126 | PDCD5 levels | GCST90470182 | 2.76e-03 |
| 11127 | IDP dMRI TBSS MD Superior cerebellar peduncle R | GCST90004039 | 2.75e-03 |
| 11128 | PIKFYVE levels | GCST90470235 | 2.74e-03 |
| 11129 | BSG levels | GCST90468472 | 2.72e-03 |
| 11130 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490 | ECGA000490 | 2.71e-03 |
| 11131 | Number of incorrect matches in round | Pairs matching | UKBB00000538 | 2.71e-03 |
| 11132 | CPB1/REG1B ratio | GCST90314213 | 2.71e-03 |
| 11133 | Triacylglycerol_49:3_[M+NH4]1+ levels | GCST90060443 | 2.70e-03 |
| 11134 | Autorefraction - 6mm strong meridian (right) | Eyesight | UKBB00000076 | 2.70e-03 |
| 11135 | T1 FreeSurfer aseg Right-Putamen | GCST90384163 | 2.69e-03 |
| 11136 | SCARA5/TNC ratio | GCST90315810 | 2.69e-03 |
| 11137 | Gestational age at birth (child effect) | GCST90268421 | 2.69e-03 |
| 11138 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T22 | ECGA000022 | 2.68e-03 |
| 11139 | wg lh intensity-contrast inferiorparietal | GCST90003799 | 2.68e-03 |
| 11140 | CNTN4 levels | GCST90240786 | 2.66e-03 |
| 11141 | SCRG1 levels | GCST90470554 | 2.66e-03 |
| 11142 | BA-exvivo lh area BA1 | GCST90003207 | 2.65e-03 |
| 11143 | Glycine levels | GCST90243581 | 2.65e-03 |
| 11144 | CRKL/PLA2G4A ratio | GCST90314271 | 2.64e-03 |
| 11145 | Hair colour (natural, before greying): Red (UKB data field 1747_2) | GCST90041837 | 2.64e-03 |
| 11146 | ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cyst | GCST90454215 | 2.64e-03 |
| 11147 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320604 | 2.62e-03 |
| 11148 | Heart rate variability traits (SDNN) | GCST004734 | 2.59e-03 |
| 11149 | T1 FreeSurfer aseg Left-Pallidum | GCST90384146 | 2.57e-03 |
| 11150 | VEGFA levels | GCST90011995 | 2.57e-03 |
| 11151 | DTI TBSS FA Sagittal stratum R | GCST90384410 | 2.57e-03 |
| 11152 | RGMB levels | GCST90470464 | 2.56e-03 |
| 11153 | IDP T1 FIRST left hippocampus volume | GCST90002444 | 2.55e-03 |
| 11154 | TEK levels | GCST90012013 | 2.55e-03 |
| 11155 | RILPL2 levels | GCST90470470 | 2.53e-03 |
| 11156 | aparc-pial rh area lateralorbitofrontal | GCST90003185 | 2.53e-03 |
| 11157 | PPP2R2A levels | GCST90618122 | 2.51e-03 |
| 11158 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118) | GCST90320937 | 2.50e-03 |
| 11159 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181 | ECGU000181 | 2.50e-03 |
| 11160 | IDP T1 FAST ROIs V cerebellum VI | GCST90002567 | 2.50e-03 |
| 11161 | FUT8/SPARC ratio | GCST90314893 | 2.49e-03 |
| 11162 | PER3 levels | GCST90470210 | 2.47e-03 |
| 11163 | SCGN levels | GCST90470544 | 2.47e-03 |
| 11164 | aparc-DKTatlas rh volume parstriangularis | GCST90002911 | 2.46e-03 |
| 11165 | Retinal detachments and breaks | FING00001260 | 2.46e-03 |
| 11166 | Brussel sprout liking | GCST90094714 | 2.45e-03 |
| 11167 | Homeostasis model assessment of beta-cell function | GCST005180 | 2.45e-03 |
| 11168 | MED18/ZBTB16 ratio | GCST90315416 | 2.44e-03 |
| 11169 | DNPH1/NSFL1C ratio | GCST90314526 | 2.43e-03 |
| 11170 | Diseases of esophagus (PheCode 530) | GCST90476045 | 2.43e-03 |
| 11171 | IDP dMRI TBSS L3 Uncinate fasciculus R | GCST90004215 | 2.41e-03 |
| 11172 | LRRC37A2 levels | GCST90469802 | 2.39e-03 |
| 11173 | IDP dMRI TBSS MD Anterior limb of internal capsule R | GCST90004043 | 2.39e-03 |
| 11174 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90025115 | 2.38e-03 |
| 11175 | CTRB1/PLA2G1B ratio | GCST90314307 | 2.38e-03 |
| 11176 | ACAA1 levels | GCST90468193 | 2.37e-03 |
| 11177 | Tibia length to body height ratio | GCST90270258 | 2.37e-03 |
| 11178 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000714 | 2.36e-03 |
| 11179 | Childhood asthma (age<16) (more control exclusions) | FING00000270 | 2.36e-03 |
| 11180 | Mean reticulocyte volume (UKB data field 30260) | GCST90468088 | 2.36e-03 |
| 11181 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000720 | 2.35e-03 |
| 11182 | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302719 | 2.35e-03 |
| 11183 | Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000428 | 2.35e-03 |
| 11184 | Impedance of whole body (UKB data field 23106) | GCST90468173 | 2.35e-03 |
| 11185 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000715 | 2.35e-03 |
| 11186 | T1 FreeSurfer DK lh lateraloccipital area | GCST90385598 | 2.33e-03 |
| 11187 | Breast cancer | GCST90011804 | 2.33e-03 |
| 11188 | X-17357 levels | GCST90200550 | 2.31e-03 |
| 11189 | Healthspan | GCST007406 | 2.31e-03 |
| 11190 | aparc-a2009s rh area S-subparietal | GCST90003441 | 2.30e-03 |
| 11191 | Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers) | FING00000316 | 2.30e-03 |
| 11192 | RAD23B levels | GCST90470418 | 2.30e-03 |
| 11193 | Coagulation defects (PheCode 286) | GCST90475796 | 2.28e-03 |
| 11194 | Phosphatidylcholine diacyl C38:4 levels | GCST90240046 | 2.27e-03 |
| 11195 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T33 | ECGA000033 | 2.27e-03 |
| 11196 | Alanine levels | GCST90497085 | 2.26e-03 |
| 11197 | aparc-pial rh area TotalSurface | GCST90003174 | 2.25e-03 |
| 11198 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T49 | ECGU000049 | 2.24e-03 |
| 11199 | Chicken liking | GCST90094732 | 2.22e-03 |
| 11200 | Lower back pain or/and sciatica | FING00000731 | 2.22e-03 |
| 11201 | Chained arithmetic | Fluid intelligence / reasoning | UKBB00000126 | 2.22e-03 |
| 11202 | PAPL levels | GCST90427208 | 2.21e-03 |
| 11203 | Torso length to body height ratio | GCST90270262 | 2.21e-03 |
| 11204 | aparc-Desikan rh area supramarginal | GCST90003137 | 2.20e-03 |
| 11205 | Secondary diabetes mellitus (PheCode 249) | GCST90475655 | 2.20e-03 |
| 11206 | NMNAT1 levels | GCST90470057 | 2.20e-03 |
| 11207 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T191 | ECGA000191 | 2.20e-03 |
| 11208 | Other dorsopathies, not elsewhere classified | FING00001041 | 2.20e-03 |
| 11209 | FCN1 levels | GCST90618565 | 2.19e-03 |
| 11210 | Autorefraction - 6mm strong meridian angle (left) | Eyesight | UKBB00000077 | 2.18e-03 |
| 11211 | Other aneurysm (PheCode 442) | GCST90475992 | 2.18e-03 |
| 11212 | PADI4 levels | GCST90470143 | 2.18e-03 |
| 11213 | Operation code - pilonidal sinus surgery (anal) | Operations | UKBB00000563 | 2.17e-03 |
| 11214 | Comparative height size at age 10 | Early life factors | UKBB00000143 | 2.16e-03 |
| 11215 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T10 | ECGU000010 | 2.15e-03 |
| 11216 | Type 2 diabetes | GCST010118 | 2.13e-03 |
| 11217 | HippSubfield lh volume Whole-hippocampus | GCST90002689 | 2.13e-03 |
| 11218 | Shoulder width to body height ratio | GCST90270261 | 2.12e-03 |
| 11219 | DTI TBSS MD Superior fronto-occipital fasciculus L | GCST90384615 | 2.12e-03 |
| 11220 | Triglyceride to HDL cholesterol ratio | GCST90295953 | 2.10e-03 |
| 11221 | aparc-a2009s rh volume G-front-inf-Triangul | GCST90003012 | 2.10e-03 |
| 11222 | Right-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivity | GCST90302780 | 2.09e-03 |
| 11223 | aparc-Desikan lh thickness GlobalMeanThickness | GCST90003445 | 2.09e-03 |
| 11224 | Disorders of the thyroid gland | FING00000463 | 2.09e-03 |
| 11225 | T1 FreeSurfer DK rh MeanThickness thickness | GCST90385757 | 2.06e-03 |
| 11226 | Bicarbonate (minimum, inv-norm transformed) | GCST90475150 | 2.05e-03 |
| 11227 | AXIN1/BACH1 ratio | GCST90313400 | 2.05e-03 |
| 11228 | Arm fat-free mass (left) | Impedance measures | UKBB00000047 | 2.05e-03 |
| 11229 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000721 | 2.03e-03 |
| 11230 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 98) | GCST90320661 | 2.02e-03 |
| 11231 | Qualifications - NVQ or HND or HNC or equivalent | Education | UKBB00000730 | 2.02e-03 |
| 11232 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 95) | GCST90320658 | 2.01e-03 |
| 11233 | Dermatitis | FING00000401 | 2.01e-03 |
| 11234 | SPESP1 levels | GCST90470720 | 2.01e-03 |
| 11235 | Renal tubulo-interstitial diseases | FING00001251 | 2.01e-03 |
| 11236 | FEV1 FVC ratio Z score (UKB data field 20258) | GCST90468165 | 2.00e-03 |
| 11237 | PDP1 levels | GCST90424296 | 1.99e-03 |
| 11238 | Pulmonary embolism | GCST90468148 | 1.99e-03 |
| 11239 | Iron deficiency anemia secondary to blood loss (chronic) (PheCode 280.2) | GCST90475770 | 1.99e-03 |
| 11240 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477 | ECGU000477 | 1.99e-03 |
| 11241 | T1 FreeSurfer aseg MaskVol-to-eTIV | GCST90384192 | 1.98e-03 |
| 11242 | Coxarthrosis, primary | FING00000363 | 1.98e-03 |
| 11243 | IDP T1 FAST ROIs L intracalc cortex | GCST90002497 | 1.98e-03 |
| 11244 | Getting up in morning | Sleep | UKBB00000285 | 1.98e-03 |
| 11245 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T447 | ECGU000447 | 1.97e-03 |
| 11246 | Glaucoma (multi-trait analysis) | GCST009722 | 1.97e-03 |
| 11247 | Prescriptions - latanoprost | prostaglandin analog | UKBB00000686 | 1.95e-03 |
| 11248 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T443 | ECGU000443 | 1.94e-03 |
| 11249 | STX6 levels | GCST90470774 | 1.94e-03 |
| 11250 | Right-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302794 | 1.94e-03 |
| 11251 | PMVK/PRTFDC1 ratio | GCST90315695 | 1.94e-03 |
| 11252 | Right ventricular end systolic volume | GCST90268118 | 1.93e-03 |
| 11253 | GERD (PheCode 530.11) | GCST90476047 | 1.92e-03 |
| 11254 | Intra-ocular pressure, corneal-compensated (left) | Intraocular pressure | UKBB00000374 | 1.92e-03 |
| 11255 | Autorefraction - 3mm cylindrical power angle (left) | Eyesight | UKBB00000064 | 1.92e-03 |
| 11256 | Acquired deformities of fingers and toes | Other joint disorders | UKBB00000006 | 1.92e-03 |
| 11257 | Sequelae of cerebrovascular disease | FING00001294 | 1.91e-03 |
| 11258 | Left-hemisphere salience/ventral attention network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302713 | 1.91e-03 |
| 11259 | Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney disease | GCST90264674 | 1.90e-03 |
| 11260 | Hip fracture | GCST90161240 | 1.90e-03 |
| 11261 | Trunk fat-free mass | Impedance measures | UKBB00000865 | 1.89e-03 |
| 11262 | Height | GCST90278637 | 1.88e-03 |
| 11263 | IDP dMRI ProbtrackX FA unc r | GCST90003951 | 1.88e-03 |
| 11264 | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | GCST90004117 | 1.86e-03 |
| 11265 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171 | ECGA000171 | 1.86e-03 |
| 11266 | Other peripheral vertigo | FING00001088 | 1.85e-03 |
| 11267 | aparc-Desikan lh area fusiform | GCST90003079 | 1.85e-03 |
| 11268 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108) | GCST90320927 | 1.85e-03 |
| 11269 | Pain in joint | FING00001137 | 1.84e-03 |
| 11270 | Pyruvate levels (UKB data field 23472) | GCST90269569 | 1.84e-03 |
| 11271 | SEPHS1 levels | GCST90242740 | 1.83e-03 |
| 11272 | MAP3K5/ZBTB16 ratio | GCST90315380 | 1.83e-03 |
| 11273 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000716 | 1.82e-03 |
| 11274 | IDP dMRI TBSS MD Uncinate fasciculus R | GCST90004071 | 1.82e-03 |
| 11275 | Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57) | GCST90668735 | 1.80e-03 |
| 11276 | Sleep apnea | GCST90475824 | 1.80e-03 |
| 11277 | CTRC/KIRREL2 ratio | GCST90314309 | 1.79e-03 |
| 11278 | WFIKKN1 levels | GCST90471076 | 1.79e-03 |
| 11279 | IDP dMRI ProbtrackX L1 cgh l | GCST90004252 | 1.79e-03 |
| 11280 | aparc-a2009s rh volume S-calcarine | GCST90003042 | 1.79e-03 |
| 11281 | Height, inverse-rank normalized | FING00000607 | 1.78e-03 |
| 11282 | N-acetyltaurine levels | GCST90199967 | 1.78e-03 |
| 11283 | aparc-DKTatlas rh volume parahippocampal | GCST90002907 | 1.76e-03 |
| 11284 | CKAP4/LTBR ratio | GCST90314074 | 1.76e-03 |
| 11285 | DTI TBSS L2 Anterior corona radiata L | GCST90384499 | 1.76e-03 |
| 11286 | DSG4 levels | GCST90469044 | 1.75e-03 |
| 11287 | Cystitis | FING00000376 | 1.74e-03 |
| 11288 | Left-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302750 | 1.74e-03 |
| 11289 | Mean reticulocyte volume | GCST90002396 | 1.72e-03 |
| 11290 | IDP T1 FAST ROIs L occ pole | GCST90002545 | 1.71e-03 |
| 11291 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T203 | ECGA000203 | 1.71e-03 |
| 11292 | Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels | GCST90200013 | 1.71e-03 |
| 11293 | Diastolic blood pressure | GCST90301699 | 1.71e-03 |
| 11294 | Pregnenetriol sulfate levels | GCST90200241 | 1.70e-03 |
| 11295 | Lysophosphatidylcholine (22:0) [sn2] levels | GCST90024176 | 1.70e-03 |
| 11296 | Postinflammatory pulmonary fibrosis (PheCode 502) | GCST90476032 | 1.69e-03 |
| 11297 | rfMRI connectivity (ICA100 edge 659) | GCST90005512 | 1.68e-03 |
| 11298 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T169 | ECGA000169 | 1.68e-03 |
| 11299 | Glomerular disorders in diseases classified elsewhere | FING00000582 | 1.68e-03 |
| 11300 | Appendicular lean mass | GCST90000026 | 1.66e-03 |
| 11301 | aparc-Desikan rh area caudalmiddlefrontal | GCST90003110 | 1.65e-03 |
| 11302 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T48 | ECGU000048 | 1.65e-03 |
| 11303 | Staphylococcus A fleurettii abundance in stool | GCST90032564 | 1.65e-03 |
| 11304 | IDP dMRI TBSS L1 Anterior limb of internal capsule R | GCST90004091 | 1.64e-03 |
| 11305 | IDP T1 FAST ROIs L precentral gyrus | GCST90002463 | 1.64e-03 |
| 11306 | Acne | FING00000010 | 1.64e-03 |
| 11307 | Perforation of tympanic membrane | FING00001155 | 1.64e-03 |
| 11308 | Autorefraction - 3mm weak meridian (left) | Eyesight | UKBB00000069 | 1.64e-03 |
| 11309 | PIK3IP1 levels | GCST90470234 | 1.63e-03 |
| 11310 | IDP dMRI TBSS L2 Anterior limb of internal capsule R | GCST90004139 | 1.63e-03 |
| 11311 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496 | ECGU000496 | 1.62e-03 |
| 11312 | Osteoarthritis | GCST90468144 | 1.62e-03 |
| 11313 | CA1/TGM2 ratio | GCST90313575 | 1.62e-03 |
| 11314 | Autorefraction - 3mm strong meridian (right) | Eyesight | UKBB00000066 | 1.62e-03 |
| 11315 | Ascending aorta diameter | GCST90267390 | 1.61e-03 |
| 11316 | DTI TBSS FA Anterior corona radiata L | GCST90384403 | 1.61e-03 |
| 11317 | Hyperplasia of prostate (PheCode 600) | GCST90476153 | 1.60e-03 |
| 11318 | GGT1/MME ratio | GCST90314930 | 1.59e-03 |
| 11319 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T497 | ECGA000497 | 1.59e-03 |
| 11320 | Autorefraction - 3mm weak meridian (right) | Eyesight | UKBB00000070 | 1.59e-03 |
| 11321 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63) | GCST90320882 | 1.57e-03 |
| 11322 | Colorectal cancer (PheCode 153) | GCST008372 | 1.57e-03 |
| 11323 | CDSN/WFDC12 ratio | GCST90313999 | 1.57e-03 |
| 11324 | Non-cancer illness code, self-reported - angina | Medical conditions | UKBB00000505 | 1.55e-03 |
| 11325 | rfMRI connectivity (ICA100 edge 1066) | GCST90005919 | 1.55e-03 |
| 11326 | Autorefraction - 3mm cylindrical power (right) | Eyesight | UKBB00000063 | 1.55e-03 |
| 11327 | Benign neoplasm: salivary glands, exclude unknown (D119) | FING00000199 | 1.54e-03 |
| 11328 | Congenital malformations of the circulatory system | FING00000340 | 1.53e-03 |
| 11329 | Right-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302817 | 1.53e-03 |
| 11330 | Multiple system atrophy | GCST90406925 | 1.53e-03 |
| 11331 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T178 | ECGU000178 | 1.52e-03 |
| 11332 | IDP dMRI TBSS L2 External capsule L | GCST90004156 | 1.52e-03 |
| 11333 | Non-insulin-dependent diabetes mellitus | Diabetes mellitus | UKBB00000524 | 1.52e-03 |
| 11334 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000717 | 1.51e-03 |
| 11335 | LCN15 levels | GCST90469746 | 1.51e-03 |
| 11336 | Varicose veins | FING00001416 | 1.50e-03 |
| 11337 | Trunk fat percentage | Impedance measures | UKBB00000864 | 1.50e-03 |
| 11338 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T202 | ECGA000202 | 1.50e-03 |
| 11339 | DTI TBSS FA Retrolenticular part of internal capsule R | GCST90384400 | 1.49e-03 |
| 11340 | Volume of left accessory basal nucleus | GCST90474940 | 1.49e-03 |
| 11341 | Optic cup area | GCST004137 | 1.49e-03 |
| 11342 | Arm fat-free mass (right) | Impedance measures | UKBB00000048 | 1.49e-03 |
| 11343 | Trunk predicted mass | Impedance measures | UKBB00000866 | 1.48e-03 |
| 11344 | Non-oily fish consumption | GCST90132994 | 1.47e-03 |
| 11345 | DOK1 levels | GCST90469028 | 1.47e-03 |
| 11346 | aparc-a2009s rh volume G-precentral | GCST90003027 | 1.46e-03 |
| 11347 | DTI autoptx L1 slf l tract | GCST90385160 | 1.45e-03 |
| 11348 | BA-exvivo rh thickness V1 | GCST90003536 | 1.45e-03 |
| 11349 | Serine levels | GCST90200415 | 1.44e-03 |
| 11350 | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | GCST90132992 | 1.43e-03 |
| 11351 | aparc-a2009s lh area G-postcentral | GCST90003324 | 1.42e-03 |
| 11352 | Red blood cell (erythrocyte) count | Blood count | UKBB00000747 | 1.42e-03 |
| 11353 | Urine 3-hydroxyindolin-2-one sulfate levels in chronic kidney disease | GCST90264508 | 1.42e-03 |
| 11354 | Leisure/social activities - Adult education class | Social support | UKBB00000398 | 1.42e-03 |
| 11355 | DTI TBSS L1 Superior longitudinal fasciculus L | GCST90384469 | 1.41e-03 |
| 11356 | HAVCR1 levels | GCST90012041 | 1.41e-03 |
| 11357 | aparc-DKTatlas rh area caudalmiddlefrontal | GCST90003267 | 1.40e-03 |
| 11358 | aseg lh volume Accumbens-area | GCST90002626 | 1.39e-03 |
| 11359 | Bread intake (UKB data field 1438) | GCST90468162 | 1.39e-03 |
| 11360 | Forced vital capacity FVC Z score (UKB data field 20257) | GCST90468167 | 1.39e-03 |
| 11361 | Anal and rectal conditions | digestive | UKBB00000029 | 1.39e-03 |
| 11362 | Arm predicted mass (right) | Impedance measures | UKBB00000050 | 1.37e-03 |
| 11363 | Autorefraction - 6mm weak meridian (right) | Eyesight | UKBB00000080 | 1.37e-03 |
| 11364 | IDP dMRI TBSS L2 Uncinate fasciculus L | GCST90004168 | 1.37e-03 |
| 11365 | Estrone 3-sulfate metabolite level | GCST90616383 | 1.35e-03 |
| 11366 | GKN2 levels | GCST90089413 | 1.35e-03 |
| 11367 | Autorefraction - 3mm strong meridian (left) | Eyesight | UKBB00000065 | 1.34e-03 |
| 11368 | Gamma glutamyl transpeptidase | GCST90018734 | 1.34e-03 |
| 11369 | CTSE levels | GCST90468911 | 1.34e-03 |
| 11370 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T257 | ECGA000257 | 1.34e-03 |
| 11371 | Type 2 diabetes, definitions combined | FING00001382 | 1.33e-03 |
| 11372 | FABP1/LGALS4 ratio | GCST90314752 | 1.32e-03 |
| 11373 | aparc-Desikan rh thickness postcentral | GCST90003500 | 1.30e-03 |
| 11374 | Exposure to tobacco smoke at home | Smoking | UKBB00000228 | 1.30e-03 |
| 11375 | Eye problems/disorders - Glaucoma | Eyesight | UKBB00000231 | 1.29e-03 |
| 11376 | Ascending aorta diameter | GCST90091050 | 1.29e-03 |
| 11377 | X-24947 levels | GCST90200651 | 1.29e-03 |
| 11378 | DTI TBSS L1 External capsule L | GCST90384461 | 1.27e-03 |
| 11379 | aparc-a2009s lh area G-oc-temp-med-Lingual | GCST90003318 | 1.26e-03 |
| 11380 | CD160 levels | GCST90468599 | 1.25e-03 |
| 11381 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T167 | ECGA000167 | 1.25e-03 |
| 11382 | N-acetylalanine levels | GCST90200303 | 1.25e-03 |
| 11383 | aparc-Desikan rh thickness paracentral | GCST90003495 | 1.25e-03 |
| 11384 | Forced expiratory volume in 1-second (FEV1), predicted | Spirometry | UKBB00000252 | 1.24e-03 |
| 11385 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3 | ECGA000003 | 1.24e-03 |
| 11386 | Type 2 diabetes | endocrine/metabolic | UKBB00000867 | 1.23e-03 |
| 11387 | aseg rh volume Caudate | GCST90002638 | 1.22e-03 |
| 11388 | HDLBP levels | GCST90087533 | 1.22e-03 |
| 11389 | Treatment or medication use - metformin (UKB data field 20003_1140884600) | GCST90042245 | 1.22e-03 |
| 11390 | Moderate to vigorous physical activity levels | GCST006097 | 1.22e-03 |
| 11391 | X-18601 levels | GCST90243501 | 1.22e-03 |
| 11392 | aparc-a2009s rh area S-collat-transv-ant | GCST90003420 | 1.21e-03 |
| 11393 | GGT1 levels | GCST90469336 | 1.20e-03 |
| 11394 | IDP T1 FAST ROIs R temporal pole | GCST90002466 | 1.20e-03 |
| 11395 | COL24A1 levels | GCST90468814 | 1.20e-03 |
| 11396 | Esophagitis, GERD and related diseases (PheCode 530.1) | GCST90476046 | 1.20e-03 |
| 11397 | Takes medication for Sleep apnea? | GCST90475258 | 1.20e-03 |
| 11398 | Pyruvate levels | GCST90092942 | 1.19e-03 |
| 11399 | Creatinine levels | GCST90278624 | 1.18e-03 |
| 11400 | Obesity (PheCode 278.1) | GCST90475762 | 1.18e-03 |
| 11401 | Uterine leiomyomata | GCST90239856 | 1.18e-03 |
| 11402 | TGFBR2 levels | GCST90470847 | 1.17e-03 |
| 11403 | Principal component-derived dietary pattern 9 | GCST90133014 | 1.16e-03 |
| 11404 | Other arrhythmias | FING00000962 | 1.16e-03 |
| 11405 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2) | GCST90320565 | 1.16e-03 |
| 11406 | TGFBR2/TNFRSF19 ratio | GCST90315917 | 1.16e-03 |
| 11407 | HippSubfield lh volume CA4-body | GCST90002683 | 1.16e-03 |
| 11408 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668524 | 1.14e-03 |
| 11409 | Estimated glomerular filtration rate, cystain C | Other measurement | UKBB00000210 | 1.14e-03 |
| 11410 | Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82) | GCST90668526 | 1.14e-03 |
| 11411 | CDH5/ENG ratio | GCST90313954 | 1.13e-03 |
| 11412 | Mean volume of bilateral amygdala | GCST90474994 | 1.13e-03 |
| 11413 | rfMRI connectivity ICA-features 6 | GCST90006344 | 1.13e-03 |
| 11414 | CD79B levels | GCST90468648 | 1.12e-03 |
| 11415 | Fasting blood glucose | GCST005186 | 1.11e-03 |
| 11416 | NCR3 levels | GCST90088179 | 1.11e-03 |
| 11417 | Operation code - haemorroidectomy / piles surgery/ banding of piles | Operations | UKBB00000557 | 1.11e-03 |
| 11418 | Autorefraction - 3mm weak meridian angle (left) | Eyesight | UKBB00000071 | 1.11e-03 |
| 11419 | Acute upper respiratory infections of multiple and unspecified sites | FING00000035 | 1.10e-03 |
| 11420 | Methods of admission to hospital (recoded) - Elective admission: Waiting List | Summary Administration | UKBB00000463 | 1.09e-03 |
| 11421 | IDP dMRI TBSS MD Anterior limb of internal capsule L | GCST90004044 | 1.09e-03 |
| 11422 | Volume of right basal nucleus | GCST90474910 | 1.09e-03 |
| 11423 | Total cholesterol levels in small LDL | GCST90132690 | 1.08e-03 |
| 11424 | Serum 25-Hydroxyvitamin D level variance | GCST90000621 | 1.08e-03 |
| 11425 | HippSubfield lh volume CA3-body | GCST90002680 | 1.07e-03 |
| 11426 | Autorefraction - 6mm weak meridian (left) | Eyesight | UKBB00000079 | 1.06e-03 |
| 11427 | Inguinal hernia | Hernia | UKBB00000363 | 1.06e-03 |
| 11428 | Diabetes, insulin treatment (Kela reimbursement) (more control exclusions) | FING00000410 | 1.05e-03 |
| 11429 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T32 | ECGA000032 | 1.05e-03 |
| 11430 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170 | ECGA000170 | 1.04e-03 |
| 11431 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T258 | ECGA000258 | 1.04e-03 |
| 11432 | Senile cataract | FING00001290 | 1.03e-03 |
| 11433 | Left bundle-branch block | FING00000716 | 1.02e-03 |
| 11434 | Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302761 | 1.01e-03 |
| 11435 | Left-hemisphere limbic network to thalamus white-matter structural connectivity | GCST90302736 | 1.01e-03 |
| 11436 | aparc-Desikan rh volume precentral | GCST90002824 | 1.01e-03 |
| 11437 | GUCA2A levels | GCST90469418 | 1.00e-03 |
| 11438 | SMAD2 levels | GCST90470676 | 1.00e-03 |
| 11439 | SERPINA5 levels | GCST90470585 | 9.99e-04 |
| 11440 | CSF2RB levels | GCST90468883 | 9.96e-04 |
| 11441 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180 | ECGU000180 | 9.96e-04 |
| 11442 | Obstructive sleep apnea (PheCode 327.32) | GCST90475825 | 9.88e-04 |
| 11443 | Leisure/social activities - None of the above | Social support | UKBB00000399 | 9.86e-04 |
| 11444 | ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrhea | GCST90454219 | 9.86e-04 |
| 11445 | HLA-E levels | GCST90469459 | 9.81e-04 |
| 11446 | Episodal and paroxysmal disorders | FING00000514 | 9.81e-04 |
| 11447 | Hyperplasia of prostate | FING00000635 | 9.76e-04 |
| 11448 | IDP dMRI TBSS ISOVF Posterior corona radiata L | GCST90004504 | 9.73e-04 |
| 11449 | BA-exvivo lh volume BA1 | GCST90002835 | 9.68e-04 |
| 11450 | Mean corpuscular hemoglobin variance | GCST90565693 | 9.67e-04 |
| 11451 | SLURP1 levels | GCST90470674 | 9.67e-04 |
| 11452 | Frequency of stair climbing in last 4 weeks | Physical activity | UKBB00000266 | 9.64e-04 |
| 11453 | Acute tubulo-interstitial nephritis | FING00000033 | 9.64e-04 |
| 11454 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168 | ECGA000168 | 9.63e-04 |
| 11455 | IDP dMRI TBSS L2 Middle cerebellar peduncle | GCST90004123 | 9.61e-04 |
| 11456 | Volume of left anterior amygdaloid area | GCST90474871 | 9.59e-04 |
| 11457 | PRSS2 levels | GCST90243126 | 9.56e-04 |
| 11458 | Prescriptions - bisoprolol | selective beta1 antagonist,beta blocker | UKBB00000672 | 9.48e-04 |
| 11459 | KYAT1 levels | GCST90469721 | 9.45e-04 |
| 11460 | DTI autoptx MD str r tract | GCST90385244 | 9.45e-04 |
| 11461 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T214 | ECGU000214 | 9.42e-04 |
| 11462 | Pulse pressure | GCST90301701 | 9.40e-04 |
| 11463 | 3-methyl-2-oxovalerate levels | GCST90243485 | 9.34e-04 |
| 11464 | Bicuspidal aortic valve syndrome | FING00000212 | 9.33e-04 |
| 11465 | Special factor anxiety/tension in mitochondrial haplogroup U | GCST90264127 | 9.20e-04 |
| 11466 | LYPD8 levels | GCST90469829 | 9.17e-04 |
| 11467 | Dihexosylceramide (d18:1/22:0) levels | GCST90025348 | 9.17e-04 |
| 11468 | Basal metabolic rate | Impedance measures | UKBB00000086 | 9.06e-04 |
| 11469 | IDP dMRI ProbtrackX OD str r | GCST90004474 | 9.05e-04 |
| 11470 | Concentration of very small VLDL particles | GCST90500819 | 9.05e-04 |
| 11471 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T465 | ECGU000465 | 8.99e-04 |
| 11472 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T48 | ECGA000048 | 8.93e-04 |
| 11473 | DTI TBSS MD Anterior limb of internal capsule L | GCST90384589 | 8.86e-04 |
| 11474 | Autorefraction - 6mm strong meridian (left) | Eyesight | UKBB00000075 | 8.85e-04 |
| 11475 | TRIM40 levels | GCST90470968 | 8.84e-04 |
| 11476 | Valine levels | GCST90132752 | 8.71e-04 |
| 11477 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 23) | GCST90320842 | 8.69e-04 |
| 11478 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T49 | ECGA000049 | 8.66e-04 |
| 11479 | Volume of left cortico-amygdaloid transition area | GCST90474880 | 8.56e-04 |
| 11480 | IDP T1 FAST ROIs R precentral gyrus | GCST90002464 | 8.52e-04 |
| 11481 | NTF4 levels | GCST90470095 | 8.50e-04 |
| 11482 | ECHDC3 levels | GCST90469062 | 8.49e-04 |
| 11483 | Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers) | FING00000041 | 8.41e-04 |
| 11484 | aparc-DKTatlas rh area supramarginal | GCST90003294 | 8.40e-04 |
| 11485 | Age at first sexual intercourse | GCST90000047 | 8.39e-04 |
| 11486 | Occupational creativity | GCST90308774 | 8.34e-04 |
| 11487 | Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers) | FING00000751 | 8.33e-04 |
| 11488 | Cholesteryl Esters to Total Lipids in Medium VLDL percentage | GCST90498944 | 8.33e-04 |
| 11489 | Body mass index | GCST90446645 | 8.32e-04 |
| 11490 | Physical function (baseline) | GCST90565837 | 8.28e-04 |
| 11491 | Melanoma in situ (controls excluding all cancers) | FING00000803 | 8.27e-04 |
| 11492 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9 | ECGU000009 | 8.24e-04 |
| 11493 | Height (baseline) | GCST90565843 | 8.24e-04 |
| 11494 | Whole body fat mass | Impedance measures | UKBB00000914 | 8.18e-04 |
| 11495 | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302715 | 8.16e-04 |
| 11496 | Acquired foot deformities | musculoskeletal | UKBB00000007 | 8.10e-04 |
| 11497 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T491 | ECGA000491 | 8.06e-04 |
| 11498 | Age when finished full-time education (standard GWA) | GCST90267280 | 8.05e-04 |
| 11499 | Volume of right lateral nucleus | GCST90474922 | 8.03e-04 |
| 11500 | Alcohol drinker status: current or former vs never (UKB data field 20117) | GCST90132923 | 8.03e-04 |
| 11501 | Other dyspnea (PheCode 512.9) | GCST90476042 | 7.99e-04 |
| 11502 | BCR/CLIP2 ratio | GCST90313486 | 7.97e-04 |
| 11503 | Time spent watching television (TV) | Physical activity | UKBB00000821 | 7.95e-04 |
| 11504 | Cholecystitis | FING00000274 | 7.87e-04 |
| 11505 | CRISP2 levels | GCST90468865 | 7.82e-04 |
| 11506 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T204 | ECGA000204 | 7.76e-04 |
| 11507 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T448 | ECGU000448 | 7.74e-04 |
| 11508 | Macular puckering of retina (PheCode 362.26) | GCST90475854 | 7.71e-04 |
| 11509 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T462 | ECGU000462 | 7.71e-04 |
| 11510 | Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney disease | GCST90266016 | 7.70e-04 |
| 11511 | Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivity | GCST90302693 | 7.67e-04 |
| 11512 | CD27/DLL1 ratio | GCST90313771 | 7.67e-04 |
| 11513 | Ceramide (d16:1/24:0) levels | GCST90024027 | 7.67e-04 |
| 11514 | Height | GCST90302890 | 7.63e-04 |
| 11515 | Ankle spacing width | Bone-densitometry of heel | UKBB00000035 | 7.61e-04 |
| 11516 | CLPP/DECR1 ratio | GCST90314137 | 7.60e-04 |
| 11517 | Right-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivity | GCST90302804 | 7.58e-04 |
| 11518 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11) | GCST90320574 | 7.53e-04 |
| 11519 | X-16087 levels | GCST90200537 | 7.52e-04 |
| 11520 | DECR1/METAP1D ratio | GCST90314448 | 7.46e-04 |
| 11521 | Volume of left cortical nucleus | GCST90474964 | 7.40e-04 |
| 11522 | aseg global volume 3rd-Ventricle | GCST90002599 | 7.37e-04 |
| 11523 | Insomnia complaints | GCST006487 | 7.35e-04 |
| 11524 | Spherical power (left) | Autorefraction | UKBB00000790 | 7.34e-04 |
| 11525 | Non-cancer illness year/age first occurred | Medical conditions | UKBB00000523 | 7.32e-04 |
| 11526 | CTRB1/KIRREL2 ratio | GCST90314306 | 7.31e-04 |
| 11527 | CRACR2A/IRAG2 ratio | GCST90314227 | 7.30e-04 |
| 11528 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T446 | ECGU000446 | 7.28e-04 |
| 11529 | Gastrointestinal issues (confirmatory factor analysis Factor 31) | GCST90309365 | 7.26e-04 |
| 11530 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34 | ECGA000034 | 7.26e-04 |
| 11531 | Lysophosphatidylcholine (26:0) [sn2] levels | GCST90024189 | 7.24e-04 |
| 11532 | Diseases of male genital organs | FING00000426 | 7.23e-04 |
| 11533 | Retinal thickness (functional principal component 1) | GCST90455721 | 7.22e-04 |
| 11534 | Impedance of leg (right) | Impedance measures | UKBB00000359 | 7.18e-04 |
| 11535 | Benign neoplasm: Parotid gland | FING00000192 | 7.10e-04 |
| 11536 | Free Cholesterol to Total Lipids in Small LDL percentage | GCST90499637 | 7.09e-04 |
| 11537 | FOLH1 levels | GCST90425661 | 7.03e-04 |
| 11538 | Body size (confirmatory factor analysis Factor 21) | GCST90309355 | 7.02e-04 |
| 11539 | aparc-DKTatlas rh volume cuneus | GCST90002896 | 7.00e-04 |
| 11540 | Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302762 | 6.97e-04 |
| 11541 | Chronic ulcer of skin, not elsewhere classified | FING00000300 | 6.96e-04 |
| 11542 | RGCC levels | GCST90470461 | 6.90e-04 |
| 11543 | Total cholesterol minus HDL-C levels | GCST90499130 | 6.87e-04 |
| 11544 | ATXN10/CASP10 ratio | GCST90313396 | 6.85e-04 |
| 11545 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487 | ECGA000487 | 6.84e-04 |
| 11546 | CDHR2 levels | GCST90468679 | 6.82e-04 |
| 11547 | Hematocrit | GCST90278634 | 6.81e-04 |
| 11548 | Endometriosis | GCST90018619 | 6.78e-04 |
| 11549 | PRR15 levels | GCST90424790 | 6.75e-04 |
| 11550 | Psoriatic arthritis | GCST90243956 | 6.71e-04 |
| 11551 | Phosphatidylcholine diacyl C38:3 levels | GCST90240045 | 6.61e-04 |
| 11552 | aseg lh intensity VentralDC | GCST90003775 | 6.58e-04 |
| 11553 | YBX1 levels | GCST90090799 | 6.56e-04 |
| 11554 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26 | ECGA000026 | 6.54e-04 |
| 11555 | Bread type: Wholemeal or wholegrain (UKB data field 1448_3) | GCST90132966 | 6.53e-04 |
| 11556 | Orotidine levels | GCST90200681 | 6.53e-04 |
| 11557 | Sleep related movement disorders (PheCode 327.7) | GCST90475827 | 6.52e-04 |
| 11558 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177 | ECGU000177 | 6.48e-04 |
| 11559 | N-acetylmethionine levels | GCST90200289 | 6.45e-04 |
| 11560 | Iliac isthmus breadth | GCST90448907 | 6.44e-04 |
| 11561 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20 | ECGA000020 | 6.44e-04 |
| 11562 | Pelvic height | GCST90448912 | 6.44e-04 |
| 11563 | Ovarian cancer-related tumor marker CA 125 levels | GCST90012078 | 6.44e-04 |
| 11564 | IDP dMRI ProbtrackX MD fma | GCST90004229 | 6.43e-04 |
| 11565 | Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302816 | 6.41e-04 |
| 11566 | CC2D1A/WWP2 ratio | GCST90313668 | 6.36e-04 |
| 11567 | Diabetes mellitus | endocrine/metabolic | UKBB00000169 | 6.20e-04 |
| 11568 | Disorders of other endocrine glands | FING00000450 | 6.12e-04 |
| 11569 | T1 FIRST volume L Puta | GCST90383987 | 6.11e-04 |
| 11570 | MYOC levels | GCST90422825 | 6.09e-04 |
| 11571 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T21 | ECGA000021 | 6.08e-04 |
| 11572 | N-acetyl-2-aminoadipate levels | GCST90200268 | 6.04e-04 |
| 11573 | Inguinal hernia | digestive | UKBB00000362 | 6.04e-04 |
| 11574 | Urinary calculus | genitourinary | UKBB00000886 | 6.03e-04 |
| 11575 | Illnesses of father - Diabetes | Family history | UKBB00000341 | 6.03e-04 |
| 11576 | ThalamNuclei lh volume CeM | GCST90002725 | 6.00e-04 |
| 11577 | Other extrapyramidal and movement disorders in other diseases | FING00001047 | 5.99e-04 |
| 11578 | Family history of certain disabilities and chronic diseases leading to disablement | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000236 | 5.99e-04 |
| 11579 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T38 | ECGA000038 | 5.99e-04 |
| 11580 | Leisure screen time | GCST90104339 | 5.98e-04 |
| 11581 | N-acetyl-1-methylhistidine levels | GCST90200690 | 5.93e-04 |
| 11582 | Angina | GCST90468109 | 5.92e-04 |
| 11583 | Alcohol drinker status - Never | Alcohol | UKBB00000022 | 5.92e-04 |
| 11584 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T495 | ECGA000495 | 5.87e-04 |
| 11585 | Other arthropathies | musculoskeletal | UKBB00000601 | 5.85e-04 |
| 11586 | Blood urea nitrogen levels | GCST90018728 | 5.83e-04 |
| 11587 | Operative procedures - Palmar fasciectomy | Summary Operations | UKBB00000586 | 5.76e-04 |
| 11588 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T179 | ECGU000179 | 5.74e-04 |
| 11589 | Asthma | GCST90086047 | 5.73e-04 |
| 11590 | Intra-ocular pressure, corneal-compensated (right) | Intraocular pressure | UKBB00000375 | 5.73e-04 |
| 11591 | Spondylopathies | FING00001325 | 5.71e-04 |
| 11592 | aparc-a2009s lh thickness Pole-occipital | GCST90003644 | 5.65e-04 |
| 11593 | Sodium in urine | Urine assays | UKBB00000785 | 5.58e-04 |
| 11594 | Peak expiratory flow (PEF) | Spirometry | UKBB00000638 | 5.55e-04 |
| 11595 | Fresh fruit intake | Diet | UKBB00000272 | 5.53e-04 |
| 11596 | HSIL lesion of the cervix uteri, vagina or vulva | FING00000625 | 5.49e-04 |
| 11597 | SFRP2 levels | GCST90242727 | 5.49e-04 |
| 11598 | Whole body fat-free mass | Impedance measures | UKBB00000915 | 5.48e-04 |
| 11599 | Alcohol drinker status: current vs never (UKB data field 20117) | GCST90132924 | 5.47e-04 |
| 11600 | ARHGAP25/RNF41 ratio | GCST90313345 | 5.38e-04 |
| 11601 | MCAM/NCAM1 ratio | GCST90315408 | 5.38e-04 |
| 11602 | S100G levels | GCST90470519 | 5.38e-04 |
| 11603 | aparc-DKTatlas rh volume precentral | GCST90002915 | 5.32e-04 |
| 11604 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T215 | ECGU000215 | 5.31e-04 |
| 11605 | Height (standard GWA) | GCST90267284 | 5.31e-04 |
| 11606 | FVC | GCST90278629 | 5.27e-04 |
| 11607 | SPINK1 levels | GCST90470721 | 5.24e-04 |
| 11608 | Lamb or mutton consumption (UKB data field 1379) | GCST90132998 | 5.23e-04 |
| 11609 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T256 | ECGA000256 | 5.22e-04 |
| 11610 | Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney disease | GCST90265175 | 5.22e-04 |
| 11611 | HippSubfield rh volume CA4-body | GCST90002705 | 5.20e-04 |
| 11612 | Barrett's esophagus (PheCode 530.13) | GCST90476048 | 5.20e-04 |
| 11613 | Arthropathy NOS | musculoskeletal | UKBB00000051 | 5.20e-04 |
| 11614 | Pulmonary embolism and infarction, acute (PheCode 415.11) | GCST90475946 | 5.20e-04 |
| 11615 | ThalamNuclei lh volume MDl | GCST90002724 | 5.18e-04 |
| 11616 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T494 | ECGA000494 | 5.15e-04 |
| 11617 | Whole body water mass | Impedance measures | UKBB00000916 | 5.15e-04 |
| 11618 | Biliary cirrhosis, NAS | FING00000213 | 5.06e-04 |
| 11619 | IDP dMRI TBSS L2 Anterior limb of internal capsule L | GCST90004140 | 5.05e-04 |
| 11620 | Volume of right anterior amygdaloid area | GCST90474904 | 5.03e-04 |
| 11621 | CTRB1 levels | GCST90468905 | 5.03e-04 |
| 11622 | Other bacterial intestinal infections | FING00000969 | 5.00e-04 |
| 11623 | Right-hemisphere limbic network to thalamus white-matter structural connectivity | GCST90302827 | 5.00e-04 |
| 11624 | DTI TBSS L3 Retrolenticular part of internal capsule L | GCST90384545 | 5.00e-04 |
| 11625 | Standing height (UKB data field 50) | GCST90468178 | 4.99e-04 |
| 11626 | Other diseases of intestine | Other diseases of intestines | UKBB00000605 | 4.97e-04 |
| 11627 | TRAF3 levels | GCST90470957 | 4.95e-04 |
| 11628 | Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000167 | 4.90e-04 |
| 11629 | Left-hemisphere control network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302748 | 4.90e-04 |
| 11630 | Waist circumference adjusted for body mass index | GCST012226 | 4.87e-04 |
| 11631 | T1 FreeSurfer aseg Left-Putamen | GCST90384145 | 4.85e-04 |
| 11632 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T42 | ECGA000042 | 4.84e-04 |
| 11633 | Left-hemisphere limbic network to putamen white-matter structural connectivity | GCST90302738 | 4.83e-04 |
| 11634 | Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary Administration | UKBB00000420 | 4.82e-04 |
| 11635 | Waist-hip ratio | GCST90278649 | 4.82e-04 |
| 11636 | diastolic blood pressure (DBP, mean, inv-normal transformed) | GCST90475255 | 4.81e-04 |
| 11637 | aparc-DKTatlas rh thickness paracentral | GCST90003586 | 4.80e-04 |
| 11638 | Globe artichoke liking | GCST90094771 | 4.77e-04 |
| 11639 | Descending aorta strain | GCST90267389 | 4.77e-04 |
| 11640 | APP/NID2 ratio | GCST90313327 | 4.75e-04 |
| 11641 | What is your height? (cm, inv-normal transformed) | GCST90475368 | 4.72e-04 |
| 11642 | Body mass index (BMI, minimum, inv-normal transformed) | GCST90475159 | 4.71e-04 |
| 11643 | Non-cancer illness code, self-reported - gastro-oesophageal reflux (gord) / gastric reflux | Medical conditions | UKBB00000510 | 4.70e-04 |
| 11644 | Macular pucker | FING00000745 | 4.68e-04 |
| 11645 | Patient classification on admission (recoded) - Day case | Summary Administration | UKBB00000636 | 4.68e-04 |
| 11646 | BTN2A1/SPINT2 ratio | GCST90313550 | 4.66e-04 |
| 11647 | 1-methylhistidine levels | GCST90199691 | 4.65e-04 |
| 11648 | Daytime dozing / sleeping (narcolepsy) | Sleep | UKBB00000164 | 4.65e-04 |
| 11649 | Knee osteoarthritis | GCST007090 | 4.60e-04 |
| 11650 | PEAR1/SPINT2 ratio | GCST90315644 | 4.58e-04 |
| 11651 | Normal-pressure hydrocephalus | FING00000891 | 4.57e-04 |
| 11652 | X-12216 levels | GCST90200483 | 4.53e-04 |
| 11653 | Other septicaemia | FING00001097 | 4.51e-04 |
| 11654 | Atherosclerosis (PheCode 440) | GCST90475989 | 4.51e-04 |
| 11655 | Variation in diet | Diet | UKBB00000892 | 4.51e-04 |
| 11656 | height (minimum, inv-normal transformed) | GCST90475365 | 4.49e-04 |
| 11657 | Ischemic heart disease (PheCode 411) | GCST008370 | 4.49e-04 |
| 11658 | aseg lh volume Cerebellum-Cortex | GCST90002619 | 4.49e-04 |
| 11659 | Operation code - appendicectomy | Operations | UKBB00000549 | 4.48e-04 |
| 11660 | Diastolic blood pressure, manual reading | Blood pressure | UKBB00000180 | 4.46e-04 |
| 11661 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000178 | 4.44e-04 |
| 11662 | Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763) | GCST90476268 | 4.42e-04 |
| 11663 | Body fat percentage (UKB data field 23099) | GCST90468160 | 4.42e-04 |
| 11664 | Standing height | Body size measures | UKBB00000796 | 4.41e-04 |
| 11665 | Obesity | endocrine/metabolic | UKBB00000544 | 4.37e-04 |
| 11666 | Prescriptions - bendroflumethiazide | thiazide diuretic,diuretic | UKBB00000667 | 4.33e-04 |
| 11667 | Trunk fat mass | Impedance measures | UKBB00000863 | 4.31e-04 |
| 11668 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320620 | 4.26e-04 |
| 11669 | T1 FreeSurfer DK lh MeanThickness thickness | GCST90385656 | 4.25e-04 |
| 11670 | BA-exvivo lh volume BA3b | GCST90002838 | 4.23e-04 |
| 11671 | CRKL/DBNL ratio | GCST90314263 | 4.22e-04 |
| 11672 | aparc-DKTatlas rh thickness lateraloccipital | GCST90003580 | 4.22e-04 |
| 11673 | Alcohol use and misuse (confirmatory factor analysis Factor 22) | GCST90309356 | 4.21e-04 |
| 11674 | Other mental disorder | mental disorders | UKBB00000614 | 4.21e-04 |
| 11675 | Other specified and unspecified disorders of lens | FING00001101 | 4.19e-04 |
| 11676 | Retinal arteriolar tortuosity | GCST90270397 | 4.18e-04 |
| 11677 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T43 | ECGA000043 | 4.17e-04 |
| 11678 | Non-cancer illness code, self-reported - glaucoma | Medical conditions | UKBB00000511 | 4.11e-04 |
| 11679 | Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523 | FING00000304 | 4.10e-04 |
| 11680 | Sciatica+with lumbago | FING00001279 | 4.07e-04 |
| 11681 | Cardiomyopathy (excluding other) | FING00000251 | 4.07e-04 |
| 11682 | IDP dMRI TBSS FA Anterior limb of internal capsule R | GCST90003893 | 4.06e-04 |
| 11683 | Liver liking | GCST90094794 | 4.04e-04 |
| 11684 | Obesity | Obesity and other hyperalimentation | UKBB00000545 | 4.03e-04 |
| 11685 | 1-arachidonoylglycerophosphoinositol levels | GCST90243754 | 4.02e-04 |
| 11686 | aparc-DKTatlas lh volume lateraloccipital | GCST90002871 | 4.02e-04 |
| 11687 | Carotid intima-media thickness (MTAG) | GCST90449061 | 4.02e-04 |
| 11688 | Left-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302678 | 4.01e-04 |
| 11689 | aparc-a2009s lh volume G-postcentral | GCST90002952 | 3.97e-04 |
| 11690 | PCOLCE levels | GCST90470175 | 3.96e-04 |
| 11691 | Ambidextrousness | GCST90013420 | 3.96e-04 |
| 11692 | height (mean, inv-normal transformed) | GCST90475362 | 3.96e-04 |
| 11693 | IDP T1 FAST ROIs L cerebellum X | GCST90002587 | 3.95e-04 |
| 11694 | Height (maximum, inv-normal transformed) | GCST90475359 | 3.94e-04 |
| 11695 | Body mass index (BMI, maximum, inv-normal transformed) | GCST90475153 | 3.91e-04 |
| 11696 | Urbanicity (confirmatory factor analysis Factor 4) | GCST90309339 | 3.89e-04 |
| 11697 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T201 | ECGA000201 | 3.88e-04 |
| 11698 | Cryptic phenotype that captures Alport syndrome severity | GCST90101828 | 3.85e-04 |
| 11699 | IDP dMRI TBSS L1 Posterior limb of internal capsule R | GCST90004093 | 3.83e-04 |
| 11700 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 13) | GCST90320576 | 3.80e-04 |
| 11701 | Left-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302767 | 3.80e-04 |
| 11702 | ATXN10/SLC27A4 ratio | GCST90313399 | 3.77e-04 |
| 11703 | O-sulfo-l-tyrosine levels | GCST90243623 | 3.77e-04 |
| 11704 | Glucose (fasting status unknown, maximum, inv-norm transformed) | GCST90475329 | 3.77e-04 |
| 11705 | Dihexosylceramide (d18:1/24:0) levels | GCST90025349 | 3.77e-04 |
| 11706 | FAM3C levels | GCST90469187 | 3.76e-04 |
| 11707 | Type 1 diabetes with neurological manifestations (PheCode 250.14) | GCST90475664 | 3.75e-04 |
| 11708 | Height | GCST90025949 | 3.74e-04 |
| 11709 | T1 FreeSurfer DKT rh supramarginal volume | GCST90384377 | 3.71e-04 |
| 11710 | aparc-DKTatlas lh volume postcentral | GCST90002882 | 3.70e-04 |
| 11711 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T444 | ECGU000444 | 3.70e-04 |
| 11712 | Forced expiratory volume in 1-second (FEV1) | Spirometry | UKBB00000251 | 3.70e-04 |
| 11713 | Seated height | Body size measures | UKBB00000763 | 3.69e-04 |
| 11714 | Osteoarthritis | GCST90134288 | 3.69e-04 |
| 11715 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79) | GCST90320898 | 3.68e-04 |
| 11716 | IDP T1 FAST ROIs R hippocampus | GCST90002556 | 3.68e-04 |
| 11717 | Hypertrophy of breast (Gynecomastia) (PheCode 612.2) | GCST90476163 | 3.67e-04 |
| 11718 | Massiliomicrobiota abundance in stool | GCST90032470 | 3.67e-04 |
| 11719 | COL1A1 levels | GCST90240744 | 3.66e-04 |
| 11720 | Calculus of ureter (PheCode 594.3) | GCST90476147 | 3.66e-04 |
| 11721 | Principal component-derived dietary pattern 29 | GCST90133034 | 3.65e-04 |
| 11722 | aseg global volume 4th-Ventricle | GCST90002600 | 3.62e-04 |
| 11723 | Current employment status - Retired | Employment | UKBB00000159 | 3.61e-04 |
| 11724 | Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000176 | 3.56e-04 |
| 11725 | BA-exvivo lh thickness V2 | GCST90003523 | 3.53e-04 |
| 11726 | Weight | Impedance measures | UKBB00000910 | 3.52e-04 |
| 11727 | Spontaneous coronary artery dissection | GCST90245878 | 3.50e-04 |
| 11728 | BMI (standard GWA) | GCST90267268 | 3.47e-04 |
| 11729 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T493 | ECGA000493 | 3.47e-04 |
| 11730 | Volume of left basal nucleus | GCST90474877 | 3.47e-04 |
| 11731 | DTI autoptx L1 cst r tract | GCST90385148 | 3.46e-04 |
| 11732 | Endometriosis | FING00000497 | 3.45e-04 |
| 11733 | Moderate visual impairment, binocular | FING00000831 | 3.45e-04 |
| 11734 | FEV1 | GCST007432 | 3.41e-04 |
| 11735 | Left-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302768 | 3.39e-04 |
| 11736 | IDP T1 FAST ROIs R cerebellum X | GCST90002589 | 3.39e-04 |
| 11737 | Diabetes mellitus (UKB data field 2443) | GCST90043627 | 3.38e-04 |
| 11738 | Insomnia | FING00000683 | 3.38e-04 |
| 11739 | Glaucoma | Glaucoma | UKBB00000286 | 3.38e-04 |
| 11740 | Waist-hip index | GCST012228 | 3.34e-04 |
| 11741 | systolic blood pressure (SBP, mean, inv-normal transformed) | GCST90476403 | 3.31e-04 |
| 11742 | aparc-Desikan lh volume postcentral | GCST90002789 | 3.29e-04 |
| 11743 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T205 | ECGA000205 | 3.29e-04 |
| 11744 | JAM2 levels | GCST90469659 | 3.28e-04 |
| 11745 | Forced vital capacity (FVC) | Spirometry | UKBB00000254 | 3.26e-04 |
| 11746 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 105) | GCST90320924 | 3.24e-04 |
| 11747 | Body mass index (BMI, mean, inv-normal transformed) | GCST90475156 | 3.18e-04 |
| 11748 | COL15A1 levels | GCST90468811 | 3.17e-04 |
| 11749 | Chronic bronchitis | GCST90018604 | 3.16e-04 |
| 11750 | Myocardial infarction (PheCode 411.2) | GCST90043954 | 3.14e-04 |
| 11751 | PPP1R14A levels | GCST90470302 | 3.14e-04 |
| 11752 | HNRNPAB levels | GCST90088693 | 3.12e-04 |
| 11753 | IDP T1 FAST ROIs L supracalc cortex | GCST90002543 | 3.11e-04 |
| 11754 | Anaphylactic shock due to adverse effect of correct drug or medication properly administered | FING00000084 | 3.09e-04 |
| 11755 | Volume of left lateral nucleus | GCST90474889 | 3.08e-04 |
| 11756 | Sebaceous cyst (PheCode 706.2) | GCST90476213 | 3.08e-04 |
| 11757 | C21orf58 levels | GCST90618380 | 3.05e-04 |
| 11758 | Glucose levels | GCST90018735 | 3.04e-04 |
| 11759 | HAO1 levels | GCST90469429 | 2.97e-04 |
| 11760 | BA-exvivo lh volume BA4p | GCST90002840 | 2.96e-04 |
| 11761 | DTI autoptx FA atr l tract | GCST90385114 | 2.88e-04 |
| 11762 | Nasal polyps | GCST90468143 | 2.88e-04 |
| 11763 | CPB1 levels | GCST90240597 | 2.87e-04 |
| 11764 | Waist-to-hip ratio adjusted for BMI | GCST012230 | 2.86e-04 |
| 11765 | Sitting height | Body size measures | UKBB00000771 | 2.86e-04 |
| 11766 | Overweight, obesity and other hyperalimentation | endocrine/metabolic | UKBB00000622 | 2.86e-04 |
| 11767 | Smoking/smokers in household | Smoking | UKBB00000783 | 2.85e-04 |
| 11768 | Phospholipid levels in large LDL | GCST90132648 | 2.84e-04 |
| 11769 | aparc-a2009s lh area S-collat-transv-ant | GCST90003346 | 2.83e-04 |
| 11770 | aseg rh volume Lateral-Ventricle | GCST90002633 | 2.81e-04 |
| 11771 | LY6D levels | GCST90469821 | 2.79e-04 |
| 11772 | Osteoporosis (PheCode 743.1) | GCST90476384 | 2.79e-04 |
| 11773 | aparc-pial lh area TotalSurface | GCST90003141 | 2.78e-04 |
| 11774 | Impedance of leg (left) | Impedance measures | UKBB00000358 | 2.77e-04 |
| 11775 | Volume of right lateral nucleus | GCST90475036 | 2.77e-04 |
| 11776 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 50) | GCST90320613 | 2.74e-04 |
| 11777 | Bicarbonate (maximum, inv-norm transformed) | GCST90475145 | 2.71e-04 |
| 11778 | DTI autoptx FA ilf l tract | GCST90385126 | 2.70e-04 |
| 11779 | Left ventricular end diastole anterospetal wall thickness | GCST90278519 | 2.70e-04 |
| 11780 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T41 | ECGA000041 | 2.70e-04 |
| 11781 | IGFBPL1 levels | GCST90179323 | 2.68e-04 |
| 11782 | MIF levels | GCST90469906 | 2.65e-04 |
| 11783 | Non-cancer illness code, self-reported - osteoarthritis | Medical conditions | UKBB00000521 | 2.64e-04 |
| 11784 | Other and unspecified polyneuropathies, also in other diseases | FING00000948 | 2.64e-04 |
| 11785 | High blood pressure / hypertension | GCST90475214 | 2.62e-04 |
| 11786 | Peak expiratory flow (UKB data field 3064) | GCST90468176 | 2.61e-04 |
| 11787 | DTI TBSS MD Retrolenticular part of internal capsule R | GCST90384592 | 2.59e-04 |
| 11788 | DTI TBSS FA Anterior corona radiata R | GCST90384402 | 2.59e-04 |
| 11789 | Ventricular arrhythmia | GCST90018720 | 2.52e-04 |
| 11790 | Diacylglycerol_36:5_[M+H-H2O]1+ levels | GCST90060187 | 2.51e-04 |
| 11791 | IDP dMRI ProbtrackX ISOVF str r | GCST90004549 | 2.51e-04 |
| 11792 | Mean volume of bilateral amygdala | GCST90474901 | 2.51e-04 |
| 11793 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T500 | ECGA000500 | 2.51e-04 |
| 11794 | Fracture of shoulder and upper arm | FING00000559 | 2.50e-04 |
| 11795 | aparc-Desikan rh thickness lateraloccipital | GCST90003489 | 2.50e-04 |
| 11796 | Body mass index (MTAG) | GCST90179150 | 2.50e-04 |
| 11797 | Left-hemisphere somatomotor network to left-hemisphere limbic network white-matter structural connectivity | GCST90302672 | 2.49e-04 |
| 11798 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | GCST90004214 | 2.49e-04 |
| 11799 | Concentration of LDL particles | GCST90498418 | 2.48e-04 |
| 11800 | Sphingomyelin (d18:1/20:0, d16:1/22:0) levels | GCST90200001 | 2.48e-04 |
| 11801 | DTI TBSS MD Fornix cres+Stria terminalis R | GCST90384610 | 2.48e-04 |
| 11802 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 70) | GCST90320889 | 2.48e-04 |
| 11803 | IDP dMRI TBSS L1 Splenium of corpus callosum | GCST90004079 | 2.47e-04 |
| 11804 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117) | GCST90320680 | 2.46e-04 |
| 11805 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 7.99_210.09) | GCST90291312 | 2.44e-04 |
| 11806 | Appendicular lean mass | GCST90000025 | 2.43e-04 |
| 11807 | Basal metabolic rate (UKB data field 23105) | GCST90468159 | 2.42e-04 |
| 11808 | PDZK1 levels | GCST90470203 | 2.42e-04 |
| 11809 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T213 | ECGU000213 | 2.39e-04 |
| 11810 | Forced expiratory volume in 1 second FEV1 Z score (UKB data field 20256) | GCST90468166 | 2.39e-04 |
| 11811 | CEACAM1/GGT1 ratio | GCST90314000 | 2.37e-04 |
| 11812 | Operation code - caesarean section / caesarian section | Operations | UKBB00000552 | 2.36e-04 |
| 11813 | Operation code - hip replacement/revision | Operations | UKBB00000558 | 2.36e-04 |
| 11814 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19 | ECGA000019 | 2.36e-04 |
| 11815 | Melanocytic naevi | FING00000797 | 2.35e-04 |
| 11816 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472 | ECGU000472 | 2.34e-04 |
| 11817 | IDP dMRI TBSS L1 Cerebral peduncle R | GCST90004089 | 2.34e-04 |
| 11818 | Weight | Body size measures | UKBB00000909 | 2.34e-04 |
| 11819 | 4-androsten-3beta,17beta-diol disulfate 2 levels | GCST90243880 | 2.33e-04 |
| 11820 | X-23641 levels | GCST90200603 | 2.33e-04 |
| 11821 | ICD10 C61: Malignant neoplasm of prostate | GCST90043894 | 2.33e-04 |
| 11822 | Acute pulmonary heart disease (PheCode 415.1) | GCST90475944 | 2.30e-04 |
| 11823 | NTRK3/SCARF2 ratio | GCST90315571 | 2.30e-04 |
| 11824 | Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressure | UKBB00000377 | 2.28e-04 |
| 11825 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320876 | 2.25e-04 |
| 11826 | GGT1/IL1RL2 ratio | GCST90314929 | 2.24e-04 |
| 11827 | 3-(4-hydroxyphenyl)lactate levels | GCST90243575 | 2.22e-04 |
| 11828 | Irritable bowel syndrome | FING00000702 | 2.21e-04 |
| 11829 | Blood urea nitrogen (BUN, mean, inv-norm transformed) | GCST90475165 | 2.21e-04 |
| 11830 | Blood cell traits latent factor 6 (red cell (and basophil)) | GCST90559248 | 2.21e-04 |
| 11831 | Subpubic angle | GCST90448908 | 2.18e-04 |
| 11832 | Free cholesterol levels in large LDL | GCST003665 | 2.16e-04 |
| 11833 | Left-hemisphere somatomotor network to left-hemisphere somatomotor network white-matter structural connectivity | GCST90302669 | 2.15e-04 |
| 11834 | IDP dMRI ProbtrackX L1 str r | GCST90004270 | 2.14e-04 |
| 11835 | Infective dermatitis | FING00000673 | 2.13e-04 |
| 11836 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442 | ECGU000442 | 2.12e-04 |
| 11837 | Right-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302805 | 2.12e-04 |
| 11838 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T466 | ECGU000466 | 2.11e-04 |
| 11839 | Dermatitis due to ingested food | FING00000403 | 2.09e-04 |
| 11840 | Cardiomyopathy | FING00000250 | 2.08e-04 |
| 11841 | SMOC2 levels | GCST90422773 | 2.08e-04 |
| 11842 | KIRREL2/PLA2G1B ratio | GCST90315251 | 2.06e-04 |
| 11843 | Cancer of prostate | neoplasms | UKBB00000118 | 2.06e-04 |
| 11844 | AMY2A levels | GCST90468298 | 2.05e-04 |
| 11845 | Calculus of kidney | genitourinary | UKBB00000115 | 2.02e-04 |
| 11846 | Concentration of large LDL particles | GCST90498029 | 2.01e-04 |
| 11847 | SWAP70 levels | GCST90242931 | 2.01e-04 |
| 11848 | Viral warts & HPV (PheCode 78) | GCST90475555 | 1.99e-04 |
| 11849 | IDP dMRI TBSS MO Superior corona radiata R | GCST90003976 | 1.98e-04 |
| 11850 | IDP dMRI TBSS L1 External capsule R | GCST90004107 | 1.98e-04 |
| 11851 | Serum urea levels | GCST90025991 | 1.95e-04 |
| 11852 | Vertical cup-disc ratio | GCST004075 | 1.95e-04 |
| 11853 | Principal component-derived dietary pattern 5 | GCST90133010 | 1.95e-04 |
| 11854 | rfMRI connectivity (ICA100 edge 399) | GCST90005252 | 1.94e-04 |
| 11855 | Operation code - bilateral oophorectomy | Operations | UKBB00000550 | 1.92e-04 |
| 11856 | Mild age-related type 2 diabetes | GCST90026416 | 1.91e-04 |
| 11857 | Total cholesterol levels in LDL | GCST90132686 | 1.89e-04 |
| 11858 | Malignant neoplasm of female breast (PheCode 174.11) | GCST90041833 | 1.89e-04 |
| 11859 | Retinal detachments and defects (PheCode 361) | GCST90475845 | 1.87e-04 |
| 11860 | aparc-a2009s lh area S-temporal-sup | GCST90003369 | 1.87e-04 |
| 11861 | Cholelithiasis | FING00000275 | 1.86e-04 |
| 11862 | aparc-Desikan lh volume lateraloccipital | GCST90002778 | 1.85e-04 |
| 11863 | T1 FreeSurfer aseg Right-choroid-plexus | GCST90384170 | 1.85e-04 |
| 11864 | Total bile acid levels in pregnancy | GCST90454198 | 1.82e-04 |
| 11865 | CELA3A/KIRREL2 ratio | GCST90314013 | 1.82e-04 |
| 11866 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90499335 | 1.80e-04 |
| 11867 | Cerebrospinal fluid S-1-pyrroline-5-carboxylate levels | GCST90318235 | 1.80e-04 |
| 11868 | Anemia in chronic kidney disease (PheCode 285.21) | GCST90475792 | 1.79e-04 |
| 11869 | ThalamNuclei rh volume VLp | GCST90002755 | 1.79e-04 |
| 11870 | Glaucoma | sense organs | UKBB00000287 | 1.79e-04 |
| 11871 | FAM3B levels | GCST90469186 | 1.78e-04 |
| 11872 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T17 | ECGA000017 | 1.77e-04 |
| 11873 | End-diastolic bi-ventricular shape (principal component 2) | GCST90448481 | 1.77e-04 |
| 11874 | Illnesses of siblings - None of the above (group 1) | Family history | UKBB00000353 | 1.76e-04 |
| 11875 | Free Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500798 | 1.76e-04 |
| 11876 | FGF2 levels | GCST90469224 | 1.76e-04 |
| 11877 | Forced expiratory volume (baseline) | GCST90565844 | 1.76e-04 |
| 11878 | Number of sexual partners in opposite-sex sexual behavior | GCST90026482 | 1.75e-04 |
| 11879 | Deaf mutism, not elsewhere classified | FING00000378 | 1.75e-04 |
| 11880 | T1 CAT volume R SupramarginalGyrusanteriordivision | GCST90384037 | 1.75e-04 |
| 11881 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486 | ECGA000486 | 1.72e-04 |
| 11882 | aparc-pial lh area cuneus | GCST90003145 | 1.72e-04 |
| 11883 | Transport type for commuting to job workplace - Public transport | Employment | UKBB00000828 | 1.70e-04 |
| 11884 | BA-exvivo lh volume entorhinal | GCST90002848 | 1.69e-04 |
| 11885 | Adenocarcinoma and papilloma adenocarcinoma of rectum | FING00000039 | 1.68e-04 |
| 11886 | Appendicular lean mass | GCST90000027 | 1.67e-04 |
| 11887 | ARG1 levels | GCST90468350 | 1.64e-04 |
| 11888 | Colonic or urogenital fistula | FING00000315 | 1.64e-04 |
| 11889 | Calculus of kidney (PheCode 594.1) | GCST90476145 | 1.63e-04 |
| 11890 | Vitiligo | FING00001443 | 1.63e-04 |
| 11891 | Stearate 18:0 levels | GCST90243431 | 1.63e-04 |
| 11892 | acne vulgaris | GCST90245818 | 1.61e-04 |
| 11893 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T498 | ECGA000498 | 1.60e-04 |
| 11894 | Takes medication for prostate cancer? | GCST90475187 | 1.60e-04 |
| 11895 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470 | ECGU000470 | 1.58e-04 |
| 11896 | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) metabolite level | GCST90615670 | 1.58e-04 |
| 11897 | Treatment speciality of consultant (recoded) - Urology | Summary Administration | UKBB00000838 | 1.56e-04 |
| 11898 | Posterior thigh muscle volume | GCST90267353 | 1.56e-04 |
| 11899 | IDP dMRI TBSS ISOVF Superior corona radiata R | GCST90004501 | 1.55e-04 |
| 11900 | Trigger finger | GCST90104907 | 1.53e-04 |
| 11901 | aparc-DKTatlas lh volume parstriangularis | GCST90002880 | 1.53e-04 |
| 11902 | Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers) | FING00000755 | 1.52e-04 |
| 11903 | Left-hemisphere default mode network to accumbens white-matter structural connectivity | GCST90302773 | 1.51e-04 |
| 11904 | IDP dMRI ProbtrackX L2 atr l | GCST90004275 | 1.51e-04 |
| 11905 | KRT19 levels | GCST90469717 | 1.51e-04 |
| 11906 | HSPG2 levels | GCST90179392 | 1.49e-04 |
| 11907 | Comparative body size at age 10 | Early life factors | UKBB00000142 | 1.49e-04 |
| 11908 | CDON levels | GCST90468687 | 1.49e-04 |
| 11909 | Frailty (Factor 3 - Multimorbidity) | GCST90624049 | 1.49e-04 |
| 11910 | Osteomyelitis | FING00000911 | 1.48e-04 |
| 11911 | Keratitis | FING00000708 | 1.47e-04 |
| 11912 | Intended management of patient (recoded) - No overnight hospital stay | Summary Administration | UKBB00000366 | 1.47e-04 |
| 11913 | Urolithiasis | GCST90018715 | 1.47e-04 |
| 11914 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T255 | ECGA000255 | 1.45e-04 |
| 11915 | What is your weight? (pounds, inv-normal transformed) | GCST90476469 | 1.42e-04 |
| 11916 | Endometrial cancer | GCST006464 | 1.42e-04 |
| 11917 | Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers) | FING00000766 | 1.42e-04 |
| 11918 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471 | ECGU000471 | 1.40e-04 |
| 11919 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12 | ECGA000012 | 1.40e-04 |
| 11920 | DTI TBSS L2 Anterior corona radiata R | GCST90384498 | 1.40e-04 |
| 11921 | CPA1/CTRC ratio | GCST90314204 | 1.37e-04 |
| 11922 | PGA4 levels | GCST90470216 | 1.37e-04 |
| 11923 | IDP T1 FIRST right caudate volume | GCST90002439 | 1.36e-04 |
| 11924 | Sexual abuse | GCST90551837 | 1.36e-04 |
| 11925 | F-strong vegetable liking (derived food-liking factor) | GCST90094852 | 1.33e-04 |
| 11926 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16 | ECGA000016 | 1.33e-04 |
| 11927 | LSIL lesion of the cervix uteri | FING00000732 | 1.32e-04 |
| 11928 | aparc-a2009s rh volume G-cuneus | GCST90003009 | 1.31e-04 |
| 11929 | Whole body water mass (UKB data field 23102) | GCST90468184 | 1.31e-04 |
| 11930 | Other arthrosis | FING00000965 | 1.29e-04 |
| 11931 | aparc-a2009s rh area G-cuneus | GCST90003381 | 1.26e-04 |
| 11932 | Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factors | UKBB00000058 | 1.26e-04 |
| 11933 | Enlarged prostate (Benign prostatic hyperplasia) | GCST90475261 | 1.25e-04 |
| 11934 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3) | GCST90320822 | 1.25e-04 |
| 11935 | Other disorders of patella | FING00001032 | 1.25e-04 |
| 11936 | APOB levels | GCST90497130 | 1.25e-04 |
| 11937 | Operation code - hysterectomy | Operations | UKBB00000559 | 1.24e-04 |
| 11938 | DTI TBSS MO Corticospinal tract R | GCST90384626 | 1.23e-04 |
| 11939 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 8.07_212.10) | GCST90291805 | 1.23e-04 |
| 11940 | Other intervertebral disc disorders | FING00001063 | 1.23e-04 |
| 11941 | aparc-a2009s lh volume G-cuneus | GCST90002935 | 1.22e-04 |
| 11942 | Anemia of chronic disease (PheCode 285.2) | GCST90475790 | 1.22e-04 |
| 11943 | Fat-free mass | GCST007063 | 1.21e-04 |
| 11944 | Mother's age | Family history | UKBB00000484 | 1.17e-04 |
| 11945 | Prescriptions - prostaglandin analog | UKBB00000697 | 1.17e-04 |
| 11946 | Father's age | Family history | UKBB00000240 | 1.16e-04 |
| 11947 | Volume of left anterior amygdaloid area | GCST90474937 | 1.15e-04 |
| 11948 | Height (weighted GWA) | GCST90267285 | 1.14e-04 |
| 11949 | STROKE | FING00001336 | 1.14e-04 |
| 11950 | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | FING00000431 | 1.13e-04 |
| 11951 | Gamma glutamyltransferase | Blood biochemistry | UKBB00000275 | 1.12e-04 |
| 11952 | Glucose levels (UKB data field 30740) | GCST90468071 | 1.12e-04 |
| 11953 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320631 | 1.12e-04 |
| 11954 | Physical activity (Total log acceleration 12am-2am) | GCST90061409 | 1.11e-04 |
| 11955 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46) | GCST90320609 | 1.09e-04 |
| 11956 | Fracture of hand or wrist (PheCode 804) | GCST90476281 | 1.09e-04 |
| 11957 | Osteoarthritis (hip) | GCST007091 | 1.09e-04 |
| 11958 | aseg rh volume choroid-plexus | GCST90002646 | 1.07e-04 |
| 11959 | aparc-DKTatlas lh thickness lateraloccipital | GCST90003549 | 1.06e-04 |
| 11960 | Urine X-23518 levels in chronic kidney disease | GCST90266595 | 1.06e-04 |
| 11961 | Peak expiratory flow | GCST007430 | 1.05e-04 |
| 11962 | Volume of left whole amygdala | GCST90474898 | 1.04e-04 |
| 11963 | Urinary calculus (PheCode 594) | GCST90476143 | 1.04e-04 |
| 11964 | IDP dMRI TBSS L3 Anterior limb of internal capsule L | GCST90004188 | 1.04e-04 |
| 11965 | Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers) | FING00000865 | 1.03e-04 |
| 11966 | LSIL lesion of the cervix uteri, vagina or vulva | FING00000733 | 1.03e-04 |
| 11967 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T208 | ECGA000208 | 1.01e-04 |
| 11968 | Retinal venular tortuosity | GCST90270399 | 1.01e-04 |
| 11969 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6 | ECGA000006 | 9.98e-05 |
| 11970 | CPB1 levels | GCST90468839 | 9.97e-05 |
| 11971 | Alcohol consumption | GCST90133003 | 9.97e-05 |
| 11972 | CPB1/CTRC ratio | GCST90314209 | 9.93e-05 |
| 11973 | Other disorders of intestine | digestive | UKBB00000608 | 9.93e-05 |
| 11974 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478 | ECGU000478 | 9.90e-05 |
| 11975 | Hypertensive heart and/or renal disease (PheCode 401.2) | GCST90475924 | 9.72e-05 |
| 11976 | Body mass index (UKB data field 21001) | GCST90468161 | 9.71e-05 |
| 11977 | Prescriptions - thiazide diuretic|diuretic | UKBB00000704 | 9.64e-05 |
| 11978 | aparc-Desikan lh area postcentral | GCST90003094 | 9.58e-05 |
| 11979 | Left-hemisphere control network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302746 | 9.49e-05 |
| 11980 | End-diastolic bi-ventricular shape (principal component 5) | GCST90448484 | 9.47e-05 |
| 11981 | Lumbar disc prolapse | FING00000735 | 9.40e-05 |
| 11982 | Fresh fruit consumption | GCST90132979 | 9.39e-05 |
| 11983 | CPB1/CTRB1 ratio | GCST90314208 | 9.38e-05 |
| 11984 | Scoliosis | FING00001281 | 9.32e-05 |
| 11985 | Paracetamol of NSAID medication | FING00001145 | 9.32e-05 |
| 11986 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T31 | ECGA000031 | 9.30e-05 |
| 11987 | IDP T1 FAST ROIs R caudate | GCST90002550 | 9.19e-05 |
| 11988 | Cancer of prostate (PheCode 185) | GCST90041853 | 9.10e-05 |
| 11989 | CPB1/KIRREL2 ratio | GCST90314210 | 9.01e-05 |
| 11990 | Retinal thickness (functional principal component 4) | GCST90455724 | 9.00e-05 |
| 11991 | aparc-Desikan lh volume cuneus | GCST90002772 | 8.98e-05 |
| 11992 | Retinal detachments and breaks | Disorders of choroid and retina | UKBB00000755 | 8.94e-05 |
| 11993 | Diabetes (weighted GWA) | GCST90267279 | 8.93e-05 |
| 11994 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 20) | GCST90320839 | 8.82e-05 |
| 11995 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52) | GCST90320871 | 8.82e-05 |
| 11996 | Illnesses of siblings - Diabetes | Family history | UKBB00000350 | 8.78e-05 |
| 11997 | Other reaction to severe stress, and adjustment disorders | FING00001092 | 8.77e-05 |
| 11998 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T35 | ECGA000035 | 8.67e-05 |
| 11999 | aparc-a2009s lh thickness G-postcentral | GCST90003630 | 8.58e-05 |
| 12000 | Erythronate levels | GCST90243696 | 8.45e-05 |